Good morning :)
Switch to
Place Order

Cipla Ltd

CIPLA
Health CarePharmaceuticals
LargecapWith a market cap of ₹90,049 cr, stock is ranked 58
Low RiskStock is 1.41x as volatile as Nifty
1,115.851.70% (+18.70)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
LargecapWith a market cap of ₹90,049 cr, stock is ranked 58
Low RiskStock is 1.41x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
35.784.260.45%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
34.974.270.92%

Forecast & RatingsDetailed Forecast 

79%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Cipla Limited is a pharmaceutical company. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology & cosmetology, diabetes, HIV/AIDS, infectious diseases & critical care, malaria etc.

Brands

Cipla

Pharmaceutical company

Investor PresentationView older 

Jul 29, 2022

PDF
View Older Presentations

Brands

Cipla

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+16.84+17.48+19.43+22.04+1.53+1.55+2.40+2.52
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 2.49%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Loss of share certificate 
Announced OnSep 27, 2022

Pursuant to Regulation 39(3) of the SEBI LODR Regulations and in terms of SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022, the Company has approved the issuance of ¬タワLetter ofConfirmation¬タン on 27th September, 2022 in lieu of share certificate(s), which were reported as lost by the shareholder. | Download

Pursuant to Regulation 39(3) of the SEBI LODR Regulations and in terms of SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated 25th January, 2022, the Company has approved the issuance of ¬タワLetter ofConfirmation¬タン on 27th September, 2022 in lieu of share certificate(s), which were reported as lost by the shareholder. | Download

General updates 
Announced OnSep 22, 2022

Cipla Limited has informed the Exchange about Closure of US FDA product-specific Pre-Approval Inspection | Download

Cipla Limited has informed the Exchange about Closure of US FDA product-specific Pre-Approval Inspection | Download

Cash Dividend 
Ex. DateAug 8, 2022

Final • Div/Share: ₹ 5

See all events